$Bristol-Myers Squibb(BMY)$ vi

$Bristol-Myers Squibb(BMY)$ view order details.@Trade Feed Decoder

BMY

10-28 21:41

USBristol-Myers Squibb

Side	Price \| Filled	Realized P&L
Buy Open	42.98 200	-- Closed

Bristol-Myers Squibb

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
10-28
Trade Feed Decoder
Analysis of BMY trade: The +0.41% gain on this Bristol-Myers Squibb buy demonstrates a conservative approach given BMY's historical profile as a low-volatility pharma stock. At $42.98 entry, the trade aligns with typical defensive positioning in healthcare during uncertain markets. However, the modest gain raises questions about position sizing and exit strategy efficiency, as pharmaceutical stocks often require larger moves to justify trading costs. The trade might reflect a short-term technical play rather than fundamental conviction, given BMY's limited price momentum in recent quarters. Execution precision appears adequate for the gain size, but investors should consider whether such marginal returns align with their risk/reward parameters for blue-chip pharma exposure.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":494111938270144,"tweetId":"494111938270144","gmtCreate":1761658971447,"gmtModify":1762996389820,"author":{"id":3564014836032088,"idStr":"3564014836032088","authorId":3564014836032088,"authorIdStr":"3564014836032088","name":"惆怅人间客","avatar":"https://static.tigerbbs.com/0d3944b70ec12dc91edbbf339f306077","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.04","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":0,"starInvestorOrderShareNum":16,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":139.93,"showRor":true,"winRationPercentage":70.588235,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Bristol-Myers Squibb(BMY)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/494111938270144","repostId":0,"isVote":1,"tweetType":1,"viewCount":175,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BMY"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3564014836032088","orderId":"40949173944585216","kind":"TRADE","symbol":"BMY","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/BMY","symbolName":"Bristol-Myers Squibb","market":"US","action":"BUY","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Bristol-Myers Squibb","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":42.98,"createTime":1761658864,"filledQuantity":"200","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Bristol-Myers Squibb","contractExtraDescription":"BMY","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.0929},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":494132700361552,"commentId":"494132700361552","gmtCreate":1761663938163,"gmtModify":1761663942765,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":494111938270144,"objectIdStr":"494111938270144","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analysis of BMY trade: The +0.41% gain on this Bristol-Myers Squibb buy demonstrates a conservative approach given BMY's historical profile as a low-volatility pharma stock. At $42.98 entry, the trade aligns with typical defensive positioning in healthcare during uncertain markets. However, the modest gain raises questions about position sizing and exit strategy efficiency, as pharmaceutical stocks often require larger moves to justify trading costs. The trade might reflect a short-term technical play rather than fundamental conviction, given BMY's limited price momentum in recent quarters. Execution precision appears adequate for the gain size, but investors should consider whether such marginal returns align with their risk/reward parameters for blue-chip pharma exposure.","text":"Analysis of BMY trade: The +0.41% gain on this Bristol-Myers Squibb buy demonstrates a conservative approach given BMY's historical profile as a low-volatility pharma stock. At $42.98 entry, the trade aligns with typical defensive positioning in healthcare during uncertain markets. However, the modest gain raises questions about position sizing and exit strategy efficiency, as pharmaceutical stocks often require larger moves to justify trading costs. The trade might reflect a short-term technical play rather than fundamental conviction, given BMY's limited price momentum in recent quarters. Execution precision appears adequate for the gain size, but investors should consider whether such marginal returns align with their risk/reward parameters for blue-chip pharma exposure.","html":"Analysis of BMY trade: The +0.41% gain on this Bristol-Myers Squibb buy demonstrates a conservative approach given BMY's historical profile as a low-volatility pharma stock. At $42.98 entry, the trade aligns with typical defensive positioning in healthcare during uncertain markets. However, the modest gain raises questions about position sizing and exit strategy efficiency, as pharmaceutical stocks often require larger moves to justify trading costs. The trade might reflect a short-term technical play rather than fundamental conviction, given BMY's limited price momentum in recent quarters. Execution precision appears adequate for the gain size, but investors should consider whether such marginal returns align with their risk/reward parameters for blue-chip pharma exposure.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/494111938270144"}